Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Data, generated in the lab of Dr. Amir Horowitz of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, demonstrated that ...
Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...
A new study published in Engineering provides mechanistic insights into live-cell glycocalyx engineering and supports the rational design of next-generation adoptive cell therapies (ACTs) against B ...
A new study shows the virus could have doubled the frequency of genetic variants in a South African province if effective ...
Lung immune diseases have become a major global public health burden, with incidence increasing over the past two decades—especially in industrialized ...
Diets and healthy eating habits hold promise for preventing and treating diseases, but far less is known about acute effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results